arabinofuranosylcytosine triphosphate and B-Cell Chronic Lymphocytic Leukemia

arabinofuranosylcytosine triphosphate has been researched along with B-Cell Chronic Lymphocytic Leukemia in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's4 (50.00)18.2507
2000's3 (37.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kolb, JP1
Barge, RM; de Vries, JF; Falkenburg, JH; Willemze, R1
Nishi, R; Ueda, T; Yamauchi, T1
Gandhi, V; Keating, MJ; Plunkett, W; Robertson, LE1
Estey, E; Hagemeister, FB; Hall, R; Kantarjian, HM; Keating, MJ; McLaughlin, P; Plunkett, W; Robertson, LE1
Estey, E; Gandhi, V; Keating, MJ; Plunkett, W1
Gandhi, V; Plunkett, W1
Gandhi, V; Keating, MJ; Nowak, B; Plunkett, W1

Reviews

1 review(s) available for arabinofuranosylcytosine triphosphate and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Biochemical modulation of arabinosylcytosine for therapy of leukemias.
    Leukemia & lymphoma, 1993, Volume: 10 Suppl

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Cytarabine; Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Vidarabine

1993

Other Studies

7 other study(ies) available for arabinofuranosylcytosine triphosphate and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Ara-C induces apoptosis in resting B-CLL cells independent on cell proliferation, but involving Ara-CTP formation and inhibition of RNA synthesis.
    Haematologica, 2006, Volume: 91, Issue:7

    Topics: Apoptosis; Arabinofuranosylcytosine Triphosphate; Cell Proliferation; Cytarabine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; RNA

2006
The mechanisms of Ara-C-induced apoptosis of resting B-chronic lymphocytic leukemia cells.
    Haematologica, 2006, Volume: 91, Issue:7

    Topics: Apoptosis; Arabinofuranosylcytosine Triphosphate; Cell Proliferation; Cytarabine; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; RNA

2006
A new, simple method for quantifying gemcitabine triphosphate in cancer cells using isocratic high-performance liquid chromatography.
    Cancer science, 2006, Volume: 97, Issue:11

    Topics: Antimetabolites, Antineoplastic; Arabinofuranosylcytosine Triphosphate; Chromatography, High Pressure Liquid; Cytarabine; Deoxycytidine; Gemcitabine; HL-60 Cells; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Sensitivity and Specificity

2006
Combination of fludarabine and arabinosylcytosine for treatment of chronic lymphocytic leukemia: clinical efficacy and modulation of arabinosylcytosine pharmacology.
    Cancer chemotherapy and pharmacology, 1994, Volume: 34, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cytarabine; Drug Administration Schedule; Drug Synergism; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Survival Analysis; Treatment Outcome; Vidarabine

1994
High-dose cytosine arabinoside in chronic lymphocytic leukemia: a clinical and pharmacologic analysis.
    Leukemia & lymphoma, 1993, Volume: 10, Issue:1-2

    Topics: Aged; Arabinofuranosylcytosine Triphosphate; Cytarabine; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged

1993
Cell cycle-specific metabolism of arabinosyl nucleosides in K562 human leukemia cells.
    Cancer chemotherapy and pharmacology, 1992, Volume: 31, Issue:1

    Topics: Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cell Cycle; Cytarabine; Deoxycytidine Kinase; Drug Synergism; G1 Phase; G2 Phase; Humans; Intracellular Fluid; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Metaphase; Nucleotides; S Phase; Sensitivity and Specificity; Tumor Cells, Cultured; Vidarabine

1992
Modulation of arabinosylcytosine metabolism by arabinosyl-2-fluoroadenine in lymphocytes from patients with chronic lymphocytic leukemia: implications for combination therapy.
    Blood, 1989, Nov-01, Volume: 74, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cytarabine; Drug Evaluation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Vidarabine Phosphate

1989